Acclaro Medical UltraClear

The science

The 2910nm erbium-doped fluoride glass fiber laser sits near water's peak absorption, so it ablates with minimal residual thermal damage — "cold" ablation — while its MIXT sub-pulse technology lets the operator dial in coagulation by following each cold ablative sub-pulse with thermal sub-pulses reaching up to 1.5mm depth. Firing at up to 3000Hz with a 170-micron spot, it spares bridges of healthy tissue for fast healing, and physicians report many treatments need no injectable or even topical anesthesia. Modes scale from epidermal-only 3DMIRACL glow treatments to deep dermal remodeling approaching CO2 territory, and the fiber architecture eliminates the beam-alignment drift of free-space lasers. AAD-presented data has expanded use into scars, pigment, and darker Fitzpatrick types where CO2 is treacherous.

Patented tech

Acclaro's patented cold-ablation fiber architecture at 2910nm and the MIXT (mixed ablative/thermal sub-pulse) energy-delivery scheme are the core IP moat — no other cleared device operates this wavelength in fiber format. 3DMIRACL is the trademarked signature protocol built on top of it.

Origin

United States (Acclaro Medical, founded 2018; US operations/engineering with global corporate HQ relocated to Munich, Germany in late 2024).

Best-fit practice

Derm and plastics practices that want ablative-level outcomes with a downtime story their patients will actually accept, and medspas in affluent markets building membership programs around the 3DMIRACL tier. Wrong fit for budget-constrained startups — the entry price demands an established patient base to feed it.

Medical director & delegation

Ablative laser resurfacing sits at the restrictive end of delegation law — many states require physician, PA, or NP operation for deeper modes, with laser-certified RNs permissible in others under direct supervision. Your medical director needs ablative-laser-specific protocols, not recycled IPL paperwork.

Contraindications & screening

Active infection, history of keloids, recent isotretinoin, pregnancy, and unrealistic-downtime patients for deeper modes; herpes prophylaxis for perioral work. Notably, the cold-ablation profile makes darker Fitzpatrick types treatable with conservative settings where CO2 would be contraindicated in practice — a genuine expansion of the treatable population.

Warranty & service

Standard 1-year manufacturer warranty with extended plans typically $12,000-$18,000/year; Acclaro's service network is still small, so confirm regional coverage and loaner policy before signing. Fiber lasers have fewer field-failure modes than CO2 tubes, which partially offsets the young-company service risk.

Resale & used market

Almost no used market exists yet — the few pre-owned units surface near $100,000+ because demand outstrips supply, giving UltraClear unusually strong short-term value retention. Long-term resale depends entirely on Acclaro's survival and continued clearance momentum; treat it as a 5-7-year revenue asset.